Rising adoption of third-party quality
controls, increasing number of accredited clinical laboratories, and the rising
demand for external quality assessment support are the key factor driving
market growth.
The Molecular Quality
Controls Market is expected to grow from USD 132 million in
2018 to USD 237 million by 2024, at a CAGR of 10.2% during the forecast
period.
Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82625523
Based on product type, the molecular
controls market is divided into two major segments—instrument-specific controls
and independent controls. The independent controls segment accounted for a
larger share of the molecular controls market in 2018. The large share of this
segment is attributed to the increasing use of third-party independent quality
controls due to their benefits such as longer shelf-life and flexible use
across different reagent lots, which help reduce the cost of operations.
By analyte type, the molecular controls
market is segmented into single-analyte controls and multi-analyte controls.
Single-analyte controls dominated the molecular controls market in 2018
primarily due to the significant use of singleplex assays in hospitals and the
advantages associated with the use of single-analyte controls, such as simple
analysis & interpretation and low risk of cross-reactivity.
While North America held the largest share
of the market in 2018, Asia Pacific is estimated to grow at the highest CAGR
during the forecast period. The presence of emerging economies such as China
and India and the significant demand for high-quality and accurate diagnostic
tests from the large patient population in this region are the major factors
supporting the growth of the Asia Pacific molecular quality controls market.
Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=82625523
The prominent players in the molecular
quality controls market are SeraCare Life Sciences Inc. (US), ZeptoMetrix
Corporation (US), Bio-Rad Laboratories Inc. (US), Microbiologics Inc. (US), and
Thermo Fisher Scientific (US).
No comments:
Post a Comment